➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Harvard Business School
Colorcon
Moodys
Medtronic

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Patent: 10,066,269

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,066,269
Title:Methods for detecting and treating multiple myeloma
Abstract: The invention provides methods for using the expression levels and subcellular localization of non-coding mitochondrial RNAs to select individuals or subpopulation of individuals for treatment with an anticancer therapy for multiple myeloma. Additional methods provided herein are useful for determining whether an individual in remission for multiple myeloma following successful treatment will be likely to suffer a relapse as well as to identify individuals who have suffered a relapse of multiple myeloma.
Inventor(s): Villota Arcos; Claudio E. (Santiago, CL), Villegas Olavarria; Jaime E. (Santiago, CL), Burzio Menendez; Veronica A. (Santiago, CL), Burzio Eriz; Luis O. (Santiago, CL)
Assignee: ANDES BIOTECHNOLOGIES GLOBAL, INC. (Burlingame, CA)
Application Number:14/776,260
Patent Claims:see list of patent claims

Details for Patent 10,066,269

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24   Start Trial ANDES BIOTECHNOLOGIES GLOBAL, INC. (Burlingame, CA) 2033-03-14 RX Orphan search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial ANDES BIOTECHNOLOGIES GLOBAL, INC. (Burlingame, CA) 2033-03-14 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial ANDES BIOTECHNOLOGIES GLOBAL, INC. (Burlingame, CA) 2033-03-14 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial ANDES BIOTECHNOLOGIES GLOBAL, INC. (Burlingame, CA) 2033-03-14 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 10,066,269

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Medtronic
Johnson and Johnson
Colorcon
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.